Susquehanna Boosts Teradyne to a New Street High of $550 as It Lifts Chip Equipment Spending Forecast.
1 min read
The story
Susquehanna has set a new Street-high price target of $550 on Teradyne (TER), lifting its chip equipment spending forecast in the process. The move places TER well above recent trading levels and signals growing sell-side conviction that the broader semiconductor capital expenditure cycle is re-accelerating. Teradyne reported FY2025 revenue of $3.2B, up 13.1% year-over-year, with a 58.2% gross margin — a profile that reflects the high-value test equipment mix the company carries into any upcycle.
The Susquehanna upgrade matters because Street-high targets carry a signaling premium: they often pull consensus estimates higher and attract momentum positioning. TER is a direct play on chip equipment spend, sitting alongside names like AMAT and LRCX in the capex beneficiary basket. A $3.47 diluted EPS base gives the company relatively modest earnings leverage at current multiples, meaning the bull case depends heavily on the spending cycle materializing as Susquehanna projects.
The tension here is between an optimistic new Street-high and the current price level — if TER is already pricing in a recovery, the incremental upside from a single analyst upgrade may be limited. The bear case rests on the fact that chip equipment forecasts have been revised aggressively in both directions over the past two years, and a $550 target implies a significant multiple expansion on a $3.47 EPS base. What to watch: any incremental data points on AI-driven test equipment demand, customer capex guidance from major chip makers, and whether other sell-side firms follow Susquehanna's lead in raising forecasts.
The case — both sides
TER's 13.1% YoY revenue growth and Street-high $550 PT from Susquehanna, backed by a raised chip equipment spending forecast, suggest the test equipment upcycle is in early innings with room for further consensus estimate revisions higher.
At a $550 target implying significant multiple expansion on a $3.47 EPS base, the stock is effectively pricing in a full spending cycle recovery before foundry and logic customers have confirmed capex commitments — leaving TER exposed to a sharp de-rating if spending forecasts are cut again as they were in 2023.
The house read
Leans bullTER faces the question of whether the Susquehanna Street-high $550 target reflects genuine cycle re-acceleration or gets ahead of actual chip equipment spend data.
Wrong ifChip equipment spending forecasts have been volatile; if major foundry or logic customers cut or defer capex guidance, the cycle re-acceleration thesis collapses quickly and TER de-rates sharply. A single analyst note without broader consensus follow-through is a weak catalyst.
Published read · research, not advice